Lexicon Pharmaceuticals Inc. logo

Lexicon Pharmaceuticals Inc.

LXRX | NASDAQ
Chart Builder DCF Calculator
$2.04
-$0.01 (-0.49%)
At close: Sep 21, 2026, 4:00 PM ET
$2
-$0.04 (-1.85%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$910.6M
Enterprise Value
$715.55M
Beta
1.03
Average Volume
3.19M
Shares Outstanding (Diluted)
437.65M
Shares Change YoY
20.38%
Institutional Ownership
80.80%
Exchange
NASDAQ
ISIN
US5288723027

Price Performance

Price Change 1M
-12.4%
Price Change 3M
-5.6%
Price Change 6M
21.4%
Price Change YTD
79.0%
Price Change 1Y
75.9%
Price Change 3Y
90.7%
Price Change 5Y
-58.7%
1M CAGR (ann.)
-13.1%
1Y CAGR (ann.)
88.1%
5Y CAGR (ann.)
-15.2%
All-Time CAGR
-12.1%

Valuation

PE Ratio
-13.60
Forward PE
N/A
PEG Ratio
0.11
Forward PEG
-0.58
PS Ratio
21.85
Forward PS
45.50
PB Ratio
5.19
P/FCF Ratio
-11.37
P/Adj. FCF Ratio
-9.49
P/OCF Ratio
-11.33
EV/Sales
17.26
EV/EBIT
-13.57
EV/EBITDA
-13.69
EV/FCF
-8.98
Earnings Yield
-7.3%
FCF Yield
-8.8%
Adj. FCF Yield
-10.5%

Financial Health

Net Cash
$190.61M
Total Debt
$0
Cash & Short-Term Investments
$190.61M
Total Assets
$250.06M
Current Ratio
13.37
Quick Ratio
13.29
Debt / Equity Ratio
0.34
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
N/A
Interest Coverage
-6.50
Altman Z-Score
-3.90
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
98.8%
Operating Profit Margin
-131.4%
EBITDA Margin
-126.0%
Net Profit Margin
-147.4%
FCF Margin
-192.2%
Adj. FCF Margin
-230.3%
SBC / Revenue
38.0%
SBC Impact (per share)
-19.8%

Returns

Return on Assets
-24.4%
Return on Equity
-40.4%
Return on Invested Capital
-23.0%
Return on Capital Employed
-23.2%
Return on Tangible Assets
-29.7%

Historical Growth (CAGR)

Revenue CAGR 3Y
366.7%
Revenue CAGR 5Y
42.4%
Revenue CAGR 10Y
-12.7%
EPS CAGR 3Y
75.0%
EPS CAGR 5Y
26.4%
EPS CAGR 10Y
15.4%
FCF CAGR 3Y
46.1%
FCF CAGR 5Y
2.3%
FCF CAGR 10Y
2.7%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
14
EPS Growth Next 3Y
24.4%
Revenue Growth Next 3Y
33.7%
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
-$0.06
EPS Growth Est (next Q)
50.0%
Revenue Est (next Q)
$2.83M
Revenue Growth Est (next Q)
-80.0%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$6
Price Target Upside
194.1%

Cash Flow

Operating Cash Flow
$-79.72M
Free Cash Flow
$-79.72M
Adj. Free Cash Flow
$-95.49M
FCF Per Share
-$0.18
OCF Per Share
-$0.18
OCF/S Ratio
-192.2%

Income Statement

Revenue
$41.47M
Gross Profit
$40.99M
Operating Income
$-54.5M
EBITDA
$-52.25M
Net Income
$-61.12M
EPS (Diluted)
-$0.15
Revenue / Employee
$511.96K
Profit / Employee
$-754.53K
Employees
81

© 2026 bestshares.com. All rights reserved.